VTV Therapeutics Inc. Class AVTVT
13F holders, Q1 2024 (March 31)19holders
$23.53avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings. The largest holders were Samsara Biocapital, LLC ($4.9M), Baker Bros. Advisors LP ($2.3M) and Vanguard Group Inc. ($578K).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.3M |
| Exits | 1 | $3K |
Ownership 19 holders
| Samsara Biocapital, LLC | 0.75% | Add +405.7% | 206,784 | $4.9M |
| Baker Bros. Advisors LP | 0.03% | New | 97,314 | $2.3M |
| Vanguard Group Inc. | 0.00% | Add +4.4% | 24,558 | $578K |
| UBS Group AG | 0.00% | New | 1,457 | $34K |
| BlackRock Inc. | 0.00% | Reduce -19.5% | 1,079 | $25K |
| Morgan Stanley | 0.00% | No change | 840 | $20K |
| Planning Capital Management Corp | 0.01% | New | 625 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -50.0% | 535 | $13K |
| Osaic Holdings, Inc. | 0.00% | Add +200.0% | 150 | $4K |
| Royal Bank of Canada | 0.00% | Reduce -82.3% | 104 | $2K |
| Bank of America Corp. | 0.00% | Add +7500.0% | 76 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $894 |
| Wells Fargo & Company | 0.00% | Reduce -3.3% | 29 | $682 |
| Cornerstone Planning Group LLC | 0.00% | No change | 19 | $449 |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $353 |
| FMR LLC | 0.00% | New | 11 | $259 |
| BNP Paribas Financial Markets | 0.00% | New | 9 | $212 |
| CENTRAL TRUST Co | 0.00% | New | 5 | $118 |
| JPMorgan Chase & Co. | 0.00% | Add +100.0% | 2 | $47 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.